Adjust Text Size:change font sizechange font sizechange font sizechange font sizechange font sizechange font size

We Need You

Help advance our mission. Apply to serve on the People with Parkinson's Advisory Council.

Learn More

Grant Programs

PDF has opened eight programs that provide critical funding for Parkinson's research.

Learn More

Ending Parkinson's

PDF is increasing investment in research, health care and patient leaders, then mobilizing them to work together toward the cure.

Learn More

A New Home for Parkinson's Science

An open access journal, enabling professionals and people with PD to access the latest research.

Learn More

Slowing PD

PDF-funded scientist-clinician Oren Levy, M.D., Ph.D., wants to slow Parkinson's and he has already found some clues.

Learn More 
Your Donations Make a Difference

Your support makes the research of Dr. Hess and Dr. Earhart possible, allowing us to learn about the role of genetics and the potential of exercise in Parkinson's.

Watch Our Video & Learn More

PDF Champions: Pancakes for Parkinson's

Monday, November 30 (Lynchburg, VA)

Join Pranamya Mahankali and members of the Liberty University College of Osteopathic Medicine Student Osteopathic Medical Association (LUCOM-SOMA) for the second annual Pancakes for Parkinson's to benefit PDF. The "breakfast for dinner" event will also feature a presentation on Parkinson's and free PDF educational resources for the community.

Learn More 

Community Events

View All Upcoming Events = PDF Sponsored Events

Rapamycin Prevents Mitochondrial Dysfunction and PD Symptoms in Mouse Model

November 13, 2015

Research published September 16 in the Journal of Neuroscience finds that the drug rapamycin, an immunosuppressant drug already approved by the FDA for transplant patients, can protect brain cells and mitochondria, and ease movement symptoms in a mouse model of Parkinson’s disease (PD). Several years back, previous studies by a team at the PDF Research Center at Columbia University Medical Center, paved the way for this research by establishing the importance of rapamycin as a molecule of interest in PD therapies.

Learn More

View All News